Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarizes the results of in-depth studies, providing a comparative analysis of participating countries per...
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Paris
OECD Publishing
2006
|
Schlagworte: | |
Online-Zugang: | kostenfrei |
Zusammenfassung: | This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarizes the results of in-depth studies, providing a comparative analysis of participating countries performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.--Publisher's description. |
Beschreibung: | 1 Online-Ressource |
ISBN: | 9789264014046 |
DOI: | 10.1787/9789264014046-en |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV035473188 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 090507s2006 fr o|||| 00||| eng d | ||
020 | |a 9789264014046 |9 9789264014046 | ||
024 | 7 | |a 10.1787/9789264014046-en |2 doi | |
035 | |a (OECD)9789264014039 | ||
035 | |a (OCoLC)77560530 | ||
035 | |a (DE-599)HBZHF000000322 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
044 | |a fr |c FR | ||
049 | |a DE-12 |a DE-521 |a DE-92 |a DE-898 |a DE-860 |a DE-1049 |a DE-384 |a DE-355 |a DE-20 |a DE-29 |a DE-824 |a DE-188 |a DE-1028 |a DE-739 |a DE-861 |a DE-473 |a DE-91 |a DE-573 |a DE-19 | ||
050 | 0 | |a RS380 | |
082 | 0 | |a 615/.19 |2 22 | |
245 | 1 | 0 | |a Innovation in Pharmaceutical Biotechnology |b Comparing National Innovation Systems at the Sectoral Level |
264 | 1 | |a Paris |b OECD Publishing |c 2006 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | 3 | |a This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarizes the results of in-depth studies, providing a comparative analysis of participating countries performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.--Publisher's description. | |
650 | 4 | |a Bio-industries | |
650 | 4 | |a Biotechnologie | |
650 | 4 | |a Industrie pharmaceutique | |
650 | 4 | |a Médecine - Recherche | |
650 | 4 | |a Biomedical Technology | |
650 | 4 | |a Biotechnology | |
650 | 4 | |a Biotechnology |x Research | |
650 | 4 | |a Pharmaceutical biotechnology |x Technological innovations | |
650 | 4 | |a Research | |
650 | 4 | |a Technology, Pharmaceutical | |
650 | 0 | 7 | |a Industriepolitik |0 (DE-588)4026860-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Technologiepolitik |0 (DE-588)4184587-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Innovationsförderung |0 (DE-588)4114020-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Biopharmazie |0 (DE-588)4006890-0 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
689 | 0 | 1 | |a Biopharmazie |0 (DE-588)4006890-0 |D s |
689 | 0 | 2 | |a Innovationsförderung |0 (DE-588)4114020-5 |D s |
689 | 0 | 3 | |a Technologiepolitik |0 (DE-588)4184587-0 |D s |
689 | 0 | 4 | |a Industriepolitik |0 (DE-588)4026860-3 |D s |
689 | 0 | |5 DE-604 | |
710 | 2 | |a OECD |e Sonstige |0 (DE-588)5157-3 |4 oth | |
856 | 4 | 0 | |u https://doi.org/10.1787/9789264014046-en |x Verlag |z kostenfrei |3 Volltext |
912 | |a ZDB-13-SOC | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-017392829 |
Datensatz im Suchindex
_version_ | 1818715345854136320 |
---|---|
adam_text | |
any_adam_object | |
building | Verbundindex |
bvnumber | BV035473188 |
callnumber-first | R - Medicine |
callnumber-label | RS380 |
callnumber-raw | RS380 |
callnumber-search | RS380 |
callnumber-sort | RS 3380 |
callnumber-subject | RS - Pharmacy |
collection | ZDB-13-SOC |
ctrlnum | (OECD)9789264014039 (OCoLC)77560530 (DE-599)HBZHF000000322 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Wirtschaftswissenschaften Medizin |
doi_str_mv | 10.1787/9789264014046-en |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV035473188</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">090507s2006 fr o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789264014046</subfield><subfield code="9">9789264014046</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1787/9789264014046-en</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OECD)9789264014039</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)77560530</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHF000000322</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">fr</subfield><subfield code="c">FR</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-861</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS380</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Innovation in Pharmaceutical Biotechnology</subfield><subfield code="b">Comparing National Innovation Systems at the Sectoral Level</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="b">OECD Publishing</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarizes the results of in-depth studies, providing a comparative analysis of participating countries performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.--Publisher's description.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bio-industries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médecine - Recherche</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedical Technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield><subfield code="x">Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology</subfield><subfield code="x">Technological innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Industriepolitik</subfield><subfield code="0">(DE-588)4026860-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Technologiepolitik</subfield><subfield code="0">(DE-588)4184587-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Innovationsförderung</subfield><subfield code="0">(DE-588)4114020-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Innovationsförderung</subfield><subfield code="0">(DE-588)4114020-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Technologiepolitik</subfield><subfield code="0">(DE-588)4184587-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Industriepolitik</subfield><subfield code="0">(DE-588)4026860-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">OECD</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5157-3</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1787/9789264014046-en</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-13-SOC</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017392829</subfield></datafield></record></collection> |
id | DE-604.BV035473188 |
illustrated | Not Illustrated |
indexdate | 2024-12-17T19:01:54Z |
institution | BVB |
institution_GND | (DE-588)5157-3 |
isbn | 9789264014046 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017392829 |
oclc_num | 77560530 |
open_access_boolean | 1 |
owner | DE-12 DE-521 DE-92 DE-898 DE-BY-UBR DE-860 DE-1049 DE-384 DE-355 DE-BY-UBR DE-20 DE-29 DE-824 DE-188 DE-1028 DE-739 DE-861 DE-473 DE-BY-UBG DE-91 DE-BY-TUM DE-573 DE-19 DE-BY-UBM |
owner_facet | DE-12 DE-521 DE-92 DE-898 DE-BY-UBR DE-860 DE-1049 DE-384 DE-355 DE-BY-UBR DE-20 DE-29 DE-824 DE-188 DE-1028 DE-739 DE-861 DE-473 DE-BY-UBG DE-91 DE-BY-TUM DE-573 DE-19 DE-BY-UBM |
physical | 1 Online-Ressource |
psigel | ZDB-13-SOC |
publishDate | 2006 |
publishDateSearch | 2006 |
publishDateSort | 2006 |
publisher | OECD Publishing |
record_format | marc |
spelling | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level Paris OECD Publishing 2006 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarizes the results of in-depth studies, providing a comparative analysis of participating countries performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.--Publisher's description. Bio-industries Biotechnologie Industrie pharmaceutique Médecine - Recherche Biomedical Technology Biotechnology Biotechnology Research Pharmaceutical biotechnology Technological innovations Research Technology, Pharmaceutical Industriepolitik (DE-588)4026860-3 gnd rswk-swf Technologiepolitik (DE-588)4184587-0 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf Innovationsförderung (DE-588)4114020-5 gnd rswk-swf Biopharmazie (DE-588)4006890-0 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 s Biopharmazie (DE-588)4006890-0 s Innovationsförderung (DE-588)4114020-5 s Technologiepolitik (DE-588)4184587-0 s Industriepolitik (DE-588)4026860-3 s DE-604 OECD Sonstige (DE-588)5157-3 oth https://doi.org/10.1787/9789264014046-en Verlag kostenfrei Volltext |
spellingShingle | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level Bio-industries Biotechnologie Industrie pharmaceutique Médecine - Recherche Biomedical Technology Biotechnology Biotechnology Research Pharmaceutical biotechnology Technological innovations Research Technology, Pharmaceutical Industriepolitik (DE-588)4026860-3 gnd Technologiepolitik (DE-588)4184587-0 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Innovationsförderung (DE-588)4114020-5 gnd Biopharmazie (DE-588)4006890-0 gnd |
subject_GND | (DE-588)4026860-3 (DE-588)4184587-0 (DE-588)4045699-7 (DE-588)4114020-5 (DE-588)4006890-0 |
title | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level |
title_auth | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level |
title_exact_search | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level |
title_full | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level |
title_fullStr | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level |
title_full_unstemmed | Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level |
title_short | Innovation in Pharmaceutical Biotechnology |
title_sort | innovation in pharmaceutical biotechnology comparing national innovation systems at the sectoral level |
title_sub | Comparing National Innovation Systems at the Sectoral Level |
topic | Bio-industries Biotechnologie Industrie pharmaceutique Médecine - Recherche Biomedical Technology Biotechnology Biotechnology Research Pharmaceutical biotechnology Technological innovations Research Technology, Pharmaceutical Industriepolitik (DE-588)4026860-3 gnd Technologiepolitik (DE-588)4184587-0 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd Innovationsförderung (DE-588)4114020-5 gnd Biopharmazie (DE-588)4006890-0 gnd |
topic_facet | Bio-industries Biotechnologie Industrie pharmaceutique Médecine - Recherche Biomedical Technology Biotechnology Biotechnology Research Pharmaceutical biotechnology Technological innovations Research Technology, Pharmaceutical Industriepolitik Technologiepolitik Pharmazeutische Technologie Innovationsförderung Biopharmazie |
url | https://doi.org/10.1787/9789264014046-en |
work_keys_str_mv | AT oecd innovationinpharmaceuticalbiotechnologycomparingnationalinnovationsystemsatthesectorallevel |